Revision Total Knee Arthroplasty

4

Review clinical trials related to Revision Total Knee Arthroplasty. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

CLinical Evaluation of ANtiseptic Skin Preparation in Revision Total Joint Arthroplasty of the Hip and Knee

The goal of this clinical trial is to compare two types of skin preparation solutions (chlorhexidine gluconate-alcohol solution and povidone-iodine solution) that help eliminate harmful bacteria on the skin at the time of surgery for patients having revision arthroplasty surgery of the hip or knee. The main outcome of interest for the definitive study is the need for re-operation for a wound complication or an infection of the prosthetic joint within one year after surgery. For the pilot trial, our main interest is to determine feasibility of a definitive trial. Feasibility outcomes will include: ability to recruit patients, ability to randomize patients, ability to collect complete data, estimate the event rate of our primary outcome, ability to carry out data linkages and determine the accuracy of collected data. Participants will be contacted at two time points after surgery to complete a 5-minute survey: after 30 days, and after 1 year.

Participants needed: 400
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Sunnybrook Health Sciences CentreUpdated: Apr 24, 2026Locations: 3
Eligibility criteria

Aged 18 years or older [+1]

Revision for prosthetic joint infection or wound complication [+3]

Status: Not yet recruiting

IO Vancomycin Into the Medial Malleolus vs IV Administration in Revision TKA

Purpose of this study is to compare the efficacy of intravenous and intraosseous antibiotic administration techniques during revision total knee arthroplasty

Participants needed: 40
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: The Methodist Hospital Research InstituteUpdated: Apr 20, 2026
Eligibility criteria

Patient is undergoing a revision total knee arthroplasty where in the opinion of... [+2]

Contraindication to receiving vancomycin, cefepime, ancef, or other standard of... [+4]

Status: Not yet recruiting

Gut Microbiome in Orthopaedics: Revision Total Knee Arthroplasty

Many patients who receive knee replacement surgery must return for a revision (or repeat) surgery due to ongoing pain, stiffness, infection, or implant loosening. The role of the gut microbiome-the collection of bacteria and other microbes within the human gastrointestinal tract-is just beginning to be recognized in orthopaedics. The gut microbiome has been found to affect the immune response and bone regulation, potentially contributing to infection or loosening after total joint replacement. Antibiotics are regularly used in orthopaedic surgery to reduce the risk of infection, yet they might also harm gut microbiota and reduce their potentially beneficial effects. As a result, understanding the relationship between gut microbiota and surgical outcomes has become increasingly important. Therefore, this study aims to determine if there are differences in gut microbiota composition between patients with well-functioning knee replacements and those requiring revision knee replacements. Additional study aims include assessing inflammation, implant loosening, metal ion levels, and circulating bacteria in blood or tissue between well-functioning or failed knee replacements.

Participants needed: 30
Trial details
Biological sex: AllType: ObservationalSponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sUpdated: Sep 19, 2025Locations: 1
Eligibility criteria

Scheduled to undergo a revision TKA [+3]

Pregnancy [+4]

Status: Recruiting

Multigen Plus CCK and AMF TT Cones Follow Up Study

This study is aimed to provide a clinical and radiographic evaluation of 68 condylar-constrained Total Knee Arthroplasty (TKA) using a single type of prosthesis (Multigen Plus CCK configuration), alone or involving the AMF TT cones, in patients with joint instability or inadequate ligament function, both in complex primary and revision procedures.

Participants needed: 68
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Limacorporate S.p.aUpdated: Mar 10, 2025Locations: 3
Eligibility criteria

Male or female. [+4]

Age < 18 years old. [+4]